Acta Med. 2011, 54: 87-89
https://doi.org/10.14712/18059694.2016.26
A Delayed Fatal Metastatic Hürthle Cell Carcinoma
References
1. CC, Ezzat S, Ramyar L, Freeman JL, Asa SL. Molecular basis of Hürthle cell papillary thyroid carcinoma. J Clin Endocrinol Metab 2000;85:878–82.
2. MR, Igali L, Grama D. Hürthle cell carcinoma: diagnostic and therapeutic implications. World J Surg Onco 2004;2:27.
<https://doi.org/10.1186/1477-7819-2-27>
<PubMed>
3. I, Akcali S, Kuleci S, et al. A rare case of Hürthle cell carcinoma with endobronchial metastasis. Endocr J 2004;51:155–7.
<https://doi.org/10.1507/endocrj.51.155>
4. EL, Palme CE, Freeman J. Hürthle cell tumours: applying molecular markers to define a new management algorithm. Arch Otolaryngol Head Neck Surg 2006;132:54–8.
<https://doi.org/10.1001/archotol.132.1.54>
5. A, Di Chiara B, Reccia I, Uccheddu A. Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions and outcomes. World J Surg 2010;34:836–43.
<https://doi.org/10.1007/s00268-009-0357-z>
6. A, Sias L, Uccheddu A. Factors predicting malignancy of Hurthle cell tumors of the thyroid: influence on surgical treatment. World J Surg 2004;28:761–5.
<https://doi.org/10.1007/s00268-004-7312-9>
7. T, Saenko V, Yamashita S. Mitochondrial DNA and human thyroid diseases. Endocr J 2004;51:265–77.
<https://doi.org/10.1507/endocrj.51.265>
8. A, Hoos A, Ghossein RA, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol 2002;9:197–203.
